SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lim S. Sam)
 

Sökning: WFRF:(Lim S. Sam) > Accrual of Atherosc...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006584naa a2200793 4500
001oai:lup.lub.lu.se:6e9f890b-67eb-45ac-975b-2b491c353f69
003SwePub
008200910s2020 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/6e9f890b-67eb-45ac-975b-2b491c353f692 URI
024a https://doi.org/10.1002/art.413922 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Urowitz, Murray B.u University of Toronto4 aut
2451 0a Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort
264 c 2020-08-25
264 1b Wiley,c 2020
300 a 7 s.
520 a Objective: In previous studies, atherosclerotic vascular events (AVEs) were shown to occur in ~10% of patients with systemic lupus erythematosus (SLE). We undertook this study to investigate the annual occurrence and potential risk factors for AVEs in a multinational, multiethnic inception cohort of patients with SLE. Methods: A large 33-center cohort of SLE patients was followed up yearly between 1999 and 2017. AVEs were attributed to atherosclerosis based on SLE being inactive at the time of the AVE as well as typical atherosclerotic changes observed on imaging or pathology reports and/or evidence of atherosclerosis elsewhere. Analyses included descriptive statistics, rate of AVEs per 1,000 patient-years, and univariable and multivariable relative risk regression models. Results: Of the 1,848 patients enrolled in the cohort, 1,710 had ≥1 follow-up visit after enrollment, for a total of 13,666 patient-years. Of these 1,710 patients, 3.6% had ≥1 AVEs attributed to atherosclerosis, for an event rate of 4.6 per 1,000 patient-years. In multivariable analyses, lower AVE rates were associated with antimalarial treatment (hazard ratio [HR] 0.54 [95% confidence interval (95% CI) 0.32–0.91]), while higher AVE rates were associated with any prior vascular event (HR 4.00 [95% CI 1.55–10.30]) and a body mass index of >40 kg/m2 (HR 2.74 [95% CI 1.04–7.18]). A prior AVE increased the risk of subsequent AVEs (HR 5.42 [95% CI 3.17–9.27], P < 0.001). Conclusion: The prevalence of AVEs and the rate of AVE accrual demonstrated in the present study is much lower than that seen in previously published data. This may be related to better control of both the disease activity and classic risk factors.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
700a Gladman, Dafna D.u University of Toronto4 aut
700a Farewell, Vernonu University of Cambridge4 aut
700a Su, Jiandongu University of Toronto4 aut
700a Romero-Diaz, Juanitau Salvador Zubirán National Institute of Health Sciences and Nutrition4 aut
700a Bae, Sang Cheolu Hanyang University4 aut
700a Fortin, Paul R.u Laval University4 aut
700a Sanchez-Guerrero, Jorgeu University of Toronto4 aut
700a Clarke, Ann Elaineu University of Calgary4 aut
700a Bernatsky, Sashau McGill University Health Center4 aut
700a Gordon, Carolineu University of Birmingham4 aut
700a Hanly, John G.u Dalhousie University4 aut
700a Wallace, Daniel J.u University of California, Los Angeles4 aut
700a Isenberg, David A.u Royal Free Hospital4 aut
700a Rahman, Anisuru Royal Free Hospital4 aut
700a Merrill, Joan T.u Oklahoma Medical Research Foundation4 aut
700a Ginzler, Ellenu SUNY Downstate Health Sciences University4 aut
700a Alarcón, Graciela S.u University of Alabama4 aut
700a Chatham, W. Winnu University of Alabama4 aut
700a Petri, Michelle A.u Johns Hopkins University School of Medicine4 aut
700a Bruce, Ian N.u University of Manchester4 aut
700a Khamashta, Munther A.u King's College London,St Thomas' Hospital4 aut
700a Aranow, Cynthiau Feinstein Institute for Medical Research4 aut
700a Dooley, Mary Anneu University of North Carolina4 aut
700a Manzi, Susanu Allegheny Health Network4 aut
700a Ramsey-Goldman, Rosalindu Northwestern University4 aut
700a Nived, Olau Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital4 aut0 (Swepub:lu)reum-oni
700a Jönsen, Andreasu Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Lund SLE Research Group,Forskargrupper vid Lunds universitet,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)reum-ajo
700a Steinsson, Kristjánu National University Hospital of Iceland4 aut
700a Zoma, Asad A.u Hairmyres Hospital4 aut
700a Ruiz-Irastorza, Guillermou University of the Basque Country4 aut
700a Lim, S. Samu Emory University4 aut
700a Kalunian, Kenneth C.u University of California, San Diego4 aut
700a Ỉnanç, Muratu Istanbul University4 aut
700a van Vollenhoven, Ronaldu Academic Medical Center of University of Amsterdam (AMC)4 aut
700a Ramos-Casals, Manuelu Institutd' Investigacions Biomèdiques August Pi iSunyer (IDIBAPS)4 aut
700a Kamen, Diane L.u Medical University of South Carolina4 aut
700a Jacobsen, Sorenu Copenhagen University Hospital4 aut
700a Peschken, Christine A.u University of Manitoba4 aut
700a Askanase, Ancau Indian Institute of Technology4 aut
700a Stoll, Thomasu Cantonal Hospital of Olten4 aut
710a University of Torontob University of Cambridge4 org
773t Arthritis and Rheumatologyd : Wileyg 72:10, s. 1734-1740q 72:10<1734-1740x 2326-5191x 2326-5205
856u http://dx.doi.org/10.1002/art.41392y FULLTEXT
856u http://pure-oai.bham.ac.uk/ws/files/111107826/UrowitzMB2020Accrual.pdf
8564 8u https://lup.lub.lu.se/record/6e9f890b-67eb-45ac-975b-2b491c353f69
8564 8u https://doi.org/10.1002/art.41392

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy